Form 8-K

8-K — Health In Tech, Inc.

Accession: 0001213900-26-055824

Filed: 2026-05-13

Period: 2026-05-13

CIK: 0002019505

SIC: 6411 (INSURANCE AGENTS BROKERS & SERVICES)

Item: Results of Operations and Financial Condition

Item: Regulation FD Disclosure

Item: Financial Statements and Exhibits

Documents

8-K — ea0290619-8k_health.htm (Primary)

EX-99.1 — PRESS RELEASE DATED MAY 13, 2026 (ea029061901ex99-1.htm)

XML — IDEA: XBRL DOCUMENT (R1.htm)

8-K — CURRENT REPORT

8-K (Primary)

Filename: ea0290619-8k_health.htm · Sequence: 1

false

0002019505

2026-05-13

iso4217:USD

xbrli:shares

iso4217:USD

xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

Current Report

Pursuant to Section 13 OR 15(d) of The Securities

Exchange Act of 1934

May 13, 2026

Date of Report (Date of earliest event reported)

Health In Tech, Inc.

(Exact name of registrant as specified in its charter)

Nevada

001-42449

87-3545722

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)

701 S. Colorado Ave, Suite 1

Stuart, FL

34994

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including

area code: (888) 373-0333

N/A

(Former name or former address, if changed since

last report)

Check the appropriate box below if the Form 8-K

filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b)

of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Class A Common Stock, $0.001 par value per share

HIT

The Nasdaq Stock Market LLC

(Nasdaq Capital Market)

Indicate by check mark whether the registrant

is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities

Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company ☒

If an emerging growth company, indicate by check

mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting

standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Item 2.02. Results of Operations and Financial

Condition.

On May 13, 2026, Health In

Tech, Inc., a Nevada corporation (the “Company”) issued a press release announcing its results of operations for the quarter

ended March 31, 2026, attached hereto as Exhibit 99.1.

Item 7.01. Regulation FD Disclosure.

As disclosed in Item 2.02

above, on May 13, 2026, the Company issued a press release announcing its results of operations for the quarter ended March 31, 2026,

attached hereto as Exhibit 99.1. The information set forth in Item 7.01 of this Current Report on Form 8-K and in the attached Exhibit

99.1 are deemed to be “furnished” and shall not be deemed to be “filed” for purposes of Section 18 of the Securities

Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liabilities of that Section. The information

set forth in Items 2.02 and 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed incorporated by reference

into any filing under the Exchange Act or the Securities Act of 1933, as amended, regardless of any general incorporation language in

such filing.

Forward-Looking Statements

Certain statements in this

Current Report on Form 8-K or in the accompanying exhibits are forward-looking statements for purposes of the safe harbor provisions under

the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health

In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive

position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms

such as “may,” “will,” “should,” “design,” “target,” “aim,” “hope,”

“expect,” “could,” “intend,” “plan,” “anticipate,” “estimate,”

“believe,” “continue,” “predict,” “project,” “potential,” “goal,”

or other words that convey the uncertainty of future events or outcomes. These statements relate to future events or to Health In Tech’s

future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s

actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance

or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements

because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s

control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Some of the risks and

uncertainties, although not all risks and uncertainties, that could cause the Company’s actual results to differ materially from

those presented in its forward-looking statements are set forth in the “Risk Factors” section in the Company’s Annual

Report on Form 10-K, its Quarterly Reports on Form 10-Q, and all of its other filings with the U.S. Securities and Exchange Commission,

as such risks, uncertainties and other important factors may be updated from time to time in the Company’s subsequent reports. Any

forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other

risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.

Health In Tech undertakes no obligation to update any forward-looking statements, except as required by law.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits:

Exhibit No.

Description

99.1

Press release dated May 13, 2026.

104

Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

Pursuant to the requirements of the Securities

Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: May 13, 2026

HEALTH IN TECH, INC.

By:

/s/ Tim Johnson

Name:

Tim Johnson

Title:

Chief Executive Officer

EX-99.1 — PRESS RELEASE DATED MAY 13, 2026

EX-99.1

Filename: ea029061901ex99-1.htm · Sequence: 2

Exhibit 99.1

Health In Tech Reports First Quarter 2026 Financial

Results

Reiterates Guidance for 2026 Annual Revenue

Ranging between $45 Million and $50 Million

Stuart, FL., May 13, 2026 /PRNewswire/ —

Health In Tech, Inc. (Nasdaq: HIT) (“Health In Tech” or “Company”), an AI-enabled InsurTech platform company,

today announced its unaudited financial results for the three months ended March 31, 2026.

First Quarter 2026 Overview

● Revenue increased 9.4% to $8.8 million from $8.0

million in the first quarter of 2025.

● Platform placed plan value1

totaled $82.0 million.

● Adjusted EBITDA2 totaled $(1.3)

million, compared to $1.2 million in the first quarter of 2025, and reflected higher sales and marketing expenses for initiatives designed

to drive long-term revenue growth.

● Net loss equaled $1.6 million, or $(0.03) per

diluted share, compared to net income of $0.5 million, or $0.01 per diluted share, in the first quarter of 2025.

As of March 31, 2026

● Distribution partners, including brokers, third-party

administrators (“TPAs”) and agencies, reached 896, up 29.5% from 692 distribution partners as of March 31, 2025.

● Contracted revenue3 for the

remaining three quarters of 2026 equaled $22.9 million.

● Cash and cash equivalents totaled $10.3 million,

compared to $7.6 million as of March 31, 2025.

● Working capital totaled $15.0 million, compared

to $8.8 million as of March 31, 2025.

2026 Full Year Revenue Guidance

Health In Tech today reiterated guidance for 2026

annual revenue ranging between $45 million and $50 million, representing year-over-year growth of approximately 35% to 50%. As of March

31, 2026, the Company’s contracted revenue for the remaining three quarters of 2026 totaled $22.9 million, which the Company believes

provides useful visibility into 2026 full year revenue. Health In Tech’s revenue outlook is based on management’s current

expectations and assumptions, including continued strong demand for the Company’s AI-enabled underwriting marketplace across the

self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and

uncertainties described in Health In Tech’s filings with the SEC.

The Company expects continued growth driven by

expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional

insurance industry, where new product and service implementations typically require one to two years, Health In Tech’s AI-driven

platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development

cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance

its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.

CEO Commentary

Tim Johnson, Chief Executive Officer of Health

In Tech, commented, “In the first quarter of 2026, we continued to execute on strategic priorities to scale our innovative AI-powered

self-funded health insurance marketplace and drive revenue growth. In March, we successfully completed a private investment in public

equity financing, which provided the Company with approximately $7 million in gross proceeds. We intend to allocate a portion of these

proceeds to growth initiatives, including expanding our sales team, broadening our marketing activities, delivering new marketplace offerings,

and enhancing the technology architecture and data analytics that underpin our disruptive platform. Through these measures we aim to increase

the number of brokers, agencies, third party administrators, and carriers that utilize our efficient, cost-effective ecosystem.”

Mr. Johnson continued, “We intend for 2026

to be a year of investing for growth and launching new solutions to further penetrate the vast U.S. self-funded health insurance market.

Our recently rolled out suite of more than 100 pre-configured, customized stop-loss plans as well as our new three-year rate stabilization

program are poised to deliver meaningful revenue beginning in the second half of the year. We also are developing a data-driven offering

that integrates physiological and claims data to generate actionable insights. By layering in new capabilities such as these onto our

platform, we better serve our ecosystem partners and business employer end-clients, while creating new revenue streams and operating leverage

for Health In Tech.”

End Notes

1. Platform placed plan value (“PPPV”) represents the aggregate contractual value of self-funded

health plans with stop-loss insurance (self-funded stop-loss plans) placed through the Company’s platform, covering the duration

of the plans’ contractual terms. The contractual term is typically 12 months from the plan’s effective date.

2. Adjusted EBITDA is a non-GAAP financial measure. More information can be found in the “Non-GAAP Financial

Information” section at the end of this press release.

3. Contracted revenue represents contractually committed revenue under active policies as of the measurement

date that is expected to be recognized in future periods. Our policies are typically written for terms of 12 months, and revenue is recognized

ratably over the life of the policy.

Conference Call Details

Health In Tech will host a conference call to

discuss the financial results for the first quarter of 2026 on May 13, 2026, at 5:00 p.m. (ET). To participate in our live conference

call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).

A live audio webcast will be available via the

Investor Relations page of Health In Tech’s website at https://healthintech.com/. A replay of the webcast will be available

for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90

days.

Non-GAAP Financial Information

This release presents Adjusted EBITDA, a non-GAAP

financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted

in the United States of America (“GAAP”). Management uses Adjusted EBITDA to provide investors with additional insight into

operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an

alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to

the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Use of Forward-Looking Statements

Certain statements in this press release are forward-looking

statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking

statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition,

business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In

some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,”

“design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,”

“plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,”

“project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes.

These statements relate to future events or to Health In Tech’s future financial performance, and involve known and unknown risks,

uncertainties and other factors that may cause Health In Tech’s actual results, levels of activity, performance, or achievements

to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking

statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties

and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results,

levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech’s current views with respect

to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations,

results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech, Inc. (Nasdaq: “HIT”)

is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through

vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales

and service process for insurance companies, licensed brokers, Managing General Underwriter (“MGUs”) and third-party administrators

(“TPAs”). Health In Tech’s platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded

health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled

underwriting, claims administration and reporting integration.

Health In Tech, Inc.

Consolidated Statements of Operations

(Unaudited)

Three Months Ended

March 31,

2026

2025

Revenues

Revenues from underwriting modeling (ICE)

$ 1,468,814

$ 2,351,984

Revenues from fees (SMR)

7,302,832

5,663,000

Total revenues

8,771,646

8,014,984

Cost of revenues

4,262,247

2,659,585

Gross profit

4,509,399

5,355,399

Operating expenses

Sales and marketing expenses

2,291,601

1,090,255

General and administrative expenses

3,455,558

3,246,765

Research and development expenses

920,395

537,721

Total operating expenses

6,667,554

4,874,741

Other income:

Interest income

67,471

85,366

Other income

22,334

118,399

Total other income, net

89,805

203,765

Income (loss) before income taxes

$ (2,068,350 )

$ 684,423

Income tax benefit (expense)

480,069

(185,831 )

Net income (loss)

$ (1,588,281 )

$ 498,592

Net income (loss) per share

Basic

$ (0.03 )

$ 0.01

Diluted

$ (0.03 )

$ 0.01

Weighted average common stocks outstanding

Basic

57,353,021

54,619,858

Diluted

57,353,021

56,996,936

Health In Tech, Inc.

Consolidated Balance Sheets

(Unaudited)

March 31,

2026

December 31,

2025

Assets

Current assets

Cash and cash equivalents

$ 10,325,208

$ 7,669,754

Accounts receivable, net

3,737,647

756,288

Loans receivable, net

831,994

815,995

Other receivables, net

4,328,448

3,467,814

Deferred offering costs

170,977

Prepaid expenses and other current assets

2,864,557

3,280,148

Total current assets

22,087,854

16,160,976

Non-current assets

Software

6,708,561

6,530,894

Operating lease - right of use assets

122,328

139,940

Long-term prepaid expenses

47,464

258,151

Total non-current assets

6,878,353

6,928,985

Total assets

$ 28,966,207

$ 23,089,961

Liabilities and stockholders’ equity

Current liabilities

Accounts payable and accrued expenses

6,968,261

$ 4,188,811

Operating lease liabilities - current

78,680

76,195

Other current liabilities

891,598

Total current liabilities

7,046,941

5,156,604

Non-current liabilities

Deferred tax liabilities

273,203

757,675

Operating lease liabilities - non-current

42,915

63,617

Total non-current liabilities

316,118

821,292

Total liabilities

7,363,059

5,977,896

Stockholders’ equity

Common stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized 53,858,276 and 46,006,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively

53,858

46,006

Common stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000 shares issued and outstanding as of both March 31, 2026 and December 31, 2025

11,700

Additional paid-in capital

17,905,633

11,834,121

Retained earnings

3,631,957

5,220,238

Total stockholders’ equity

21,603,148

17,112,065

Total liabilities and stockholders’ equity

$ 28,966,207

$ 23,089,961

Health In Tech, Inc.

Consolidated Statements of Cash Flows

(Unaudited)

Three Months Ended

March 31,

2026

2025

CASH FLOWS FROM OPERATING ACTIVITIES:

Net income (loss)

$ (1,588,281 )

$ 498,592

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

Amortization expense

403,467

135,983

Provision for refund liability

108,402

780,045

Deferred tax benefit

(484,472 )

(34,473 )

Interest income

(15,999 )

Stock-based compensation expense

366,562

493,171

Changes in operating assets and liabilities:

Accounts receivable

(2,981,360 )

(463,498 )

Other receivables

(11,740 )

(3,489,536 )

Prepaid expenses and other assets

447,597

(1,017,751 )

Operating lease right of use assets and liabilities, net

(605 )

Accounts payable and accrued expenses

1,437,182

3,420,497

Income taxes payable

220,303

Other current liabilities

(1,000,000 )

Net cash provided by (used in) operating activities

(3,319,247 )

527,353

CASH FLOWS FROM INVESTING ACTIVITIES:

Development of software

(362,131 )

(703,475 )

Net cash used in investing activities

(362,131 )

(703,475 )

CASH FLOWS FROM FINANCING ACTIVITIES:

Proceeds from issuance of common stock in connection with private investment in public equity financing, net of placement agent fees and escrow agent fees

6,381,000

Payments of deferred offering costs

(44,168 )

(98,089 )

Net cash provided by (used in) financing activities

6,336,832

(98,089 )

Increase (decrease) in cash and cash equivalents

2,655,454

(274,211 )

Cash and cash equivalents, beginning of the period

7,669,754

7,849,248

Cash and cash equivalents, end of the period

10,325,208

7,575,037

Supplemental disclosures of cash flow information:

Cash paid for interest

$ -

Cash received from income tax refunds

$ 4,965

$ -

Summary of noncash investing and financing activities:

Accrued deferred offering costs included in accounts payable and accrued expenses

$ 237,734

$ 33,250

Accrued development of software included in accounts payable and accrued expenses

$ 228,518

$ 256,140

Reclassification of deferred offering costs to additional paid-in capital upon private investment in public equity financing

$ 452,880

$ -

Stock-based compensation capitalized for software development

$ 8,837

$ -

Health In Tech, Inc.

Reconciliation of GAAP Net Income (Loss) to

Non-GAAP Financial Measure Adjusted EBITDA

Three Months Ended

March 31,

2026

2025

Net income (loss)

(1,588,281 )

498,592

Interest income

(67,471 )

(85,366 )

Amortization expense

403,467

135,983

Income tax expense (benefit)

(480,069 )

185,831

Stock-based compensation expense, including employer payroll taxes related to stock-based awards

443,839

493,171

Total net adjustments

299,766

729,619

Adjusted EBITDA

(1,288,515 )

1,228,211

Investor Contact:

Health In Tech Investor Relations

ir@healthintech.com

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878

kahl@theequitygroup.com

Devin Sullivan, Managing Director

dsullivan@theequitygroup.com

XML — IDEA: XBRL DOCUMENT

XML

Filename: R1.htm · Sequence: 7

v3.26.1

Cover

May 13, 2026

Cover [Abstract]

Document Type

8-K

Amendment Flag

false

Document Period End Date

May 13, 2026

Entity File Number

001-42449

Entity Registrant Name

Health In Tech, Inc.

Entity Central Index Key

0002019505

Entity Tax Identification Number

87-3545722

Entity Incorporation, State or Country Code

Entity Address, Address Line One

701 S. Colorado Ave

Entity Address, Address Line Two

Suite 1

Entity Address, City or Town

Stuart

Entity Address, State or Province

Entity Address, Postal Zip Code

34994

City Area Code

888

Local Phone Number

373-0333

Written Communications

false

Soliciting Material

false

Pre-commencement Tender Offer

false

Pre-commencement Issuer Tender Offer

false

Title of 12(b) Security

Class A Common Stock, $0.001 par value per share

Trading Symbol

HIT

Security Exchange Name

NASDAQ

Entity Emerging Growth Company

true

Elected Not To Use the Extended Transition Period

false

- Definition

Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.

+ References

No definition available.

+ Details

Name:

dei_AmendmentFlag

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Area code of city

+ References

No definition available.

+ Details

Name:

dei_CityAreaCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Cover page.

+ References

No definition available.

+ Details

Name:

dei_CoverAbstract

Namespace Prefix:

dei_

Data Type:

xbrli:stringItemType

Balance Type:

Period Type:

duration

- Definition

For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.

+ References

No definition available.

+ Details

Name:

dei_DocumentPeriodEndDate

Namespace Prefix:

dei_

Data Type:

xbrli:dateItemType

Balance Type:

Period Type:

duration

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.

+ References

No definition available.

+ Details

Name:

dei_DocumentType

Namespace Prefix:

dei_

Data Type:

dei:submissionTypeItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 1 such as Attn, Building Name, Street Name

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine1

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Address Line 2 such as Street or Suite number

+ References

No definition available.

+ Details

Name:

dei_EntityAddressAddressLine2

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the City or Town

+ References

No definition available.

+ Details

Name:

dei_EntityAddressCityOrTown

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Code for the postal or zip code

+ References

No definition available.

+ Details

Name:

dei_EntityAddressPostalZipCode

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Name of the state or province.

+ References

No definition available.

+ Details

Name:

dei_EntityAddressStateOrProvince

Namespace Prefix:

dei_

Data Type:

dei:stateOrProvinceItemType

Balance Type:

Period Type:

duration

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityCentralIndexKey

Namespace Prefix:

dei_

Data Type:

dei:centralIndexKeyItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if registrant meets the emerging growth company criteria.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityEmergingGrowthCompany

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 7A

-Section B

-Subsection 2

+ Details

Name:

dei_EntityExTransitionPeriod

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.

+ References

No definition available.

+ Details

Name:

dei_EntityFileNumber

Namespace Prefix:

dei_

Data Type:

dei:fileNumberItemType

Balance Type:

Period Type:

duration

- Definition

Two-character EDGAR code representing the state or country of incorporation.

+ References

No definition available.

+ Details

Name:

dei_EntityIncorporationStateCountryCode

Namespace Prefix:

dei_

Data Type:

dei:edgarStateCountryItemType

Balance Type:

Period Type:

duration

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityRegistrantName

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b-2

+ Details

Name:

dei_EntityTaxIdentificationNumber

Namespace Prefix:

dei_

Data Type:

dei:employerIdItemType

Balance Type:

Period Type:

duration

- Definition

Local phone number for entity.

+ References

No definition available.

+ Details

Name:

dei_LocalPhoneNumber

Namespace Prefix:

dei_

Data Type:

xbrli:normalizedStringItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 13e

-Subsection 4c

+ Details

Name:

dei_PreCommencementIssuerTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14d

-Subsection 2b

+ Details

Name:

dei_PreCommencementTenderOffer

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Title of a 12(b) registered security.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection b

+ Details

Name:

dei_Security12bTitle

Namespace Prefix:

dei_

Data Type:

dei:securityTitleItemType

Balance Type:

Period Type:

duration

- Definition

Name of the Exchange on which a security is registered.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 12

-Subsection d1-1

+ Details

Name:

dei_SecurityExchangeName

Namespace Prefix:

dei_

Data Type:

dei:edgarExchangeCodeItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Exchange Act

-Number 240

-Section 14a

-Subsection 12

+ Details

Name:

dei_SolicitingMaterial

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name:

dei_TradingSymbol

Namespace Prefix:

dei_

Data Type:

dei:tradingSymbolItemType

Balance Type:

Period Type:

duration

- Definition

Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Securities Act

-Number 230

-Section 425

+ Details

Name:

dei_WrittenCommunications

Namespace Prefix:

dei_

Data Type:

xbrli:booleanItemType

Balance Type:

Period Type:

duration